Scinai Immunotherapeutics Ltd. Share Price
Stocks
SCNI
US09073Q4029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.860 USD | -4.62% |
|
-25.90% | -73.88% |
| 26/08 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 24/08 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 10.6L 9L 9L 8L 14.67L 10Cr 14.72L 1.01Cr 39.31L 5.13Cr 39.81L 38.94L 17Cr | P/E 2024 * |
-
| P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 16.66L 14.35L 13.48L 12.32L 23.06L 16Cr 23.14L 1.59Cr 61.78L 8.07Cr 62.56L 61.2L 26Cr | EV / Sales 2024 |
45,21,658x | EV / Sales 2025 | 23,46,086x |
| Free-Float |
0.36% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNI | Delayed | |
CBOE
| SCNI | Real-time | |
|
Tradegate
| 2F50 | Real-time | |
|
Deutsche Boerse AG
| 2F50 | Delayed |
Last Transcript : Scinai Immunotherapeutics Ltd.
| 1 day | -4.62% | ||
| 1 week | -25.90% | ||
| Current month | -25.60% | ||
| 1 month | -25.66% | ||
| 3 months | -57.63% | ||
| 6 months | -78.05% | ||
| Current year | -73.88% |
| 1 week | 1.85 |  | 2.7 |
| 1 month | 1.85 | | 3.58 |
| Current year | 1.85 | | 11.2 |
| 1 year | 1.85 | | 16.4 |
| 3 years | 1.85 | | 137 |
| 5 years | 1.85 | | 3,490 |
| 10 years | 1.85 | | 61,999.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 02/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 01/01/2007 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 30/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 24/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 24/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Other | Chief Financial Officer | 3,58,48,348 | 1.0507% | ||
| 18/03/26 | Other | Director | 5,74,00,000 | 1.6823% | ||
| 18/03/26 | Other | Director | 6,04,00,000 | 1.7702% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.62% | -25.90% | -88.08% | -98.57% | 10.6L | |
| -2.54% | -2.84% | -1.90% | +14.52% | 4.89TCr | |
| -0.40% | +1.03% | +439.20% | +499.20% | 4.5TCr | |
| -1.42% | +2.30% | +45.46% | +19.36% | 4.41TCr | |
| -1.22% | -2.31% | +12.40% | +71.48% | 4.07TCr | |
| +0.53% | -1.36% | +16.04% | +48.23% | 3.35TCr | |
| -0.21% | +9.14% | - | - | 1.78TCr | |
| -0.35% | -1.56% | +22.59% | +116.19% | 1.65TCr | |
| -1.01% | +0.50% | +15.83% | +27.98% | 1.47TCr | |
| -1.65% | -1.03% | +77.75% | +37.63% | 1.38TCr | |
| Average | -1.29% | -2.11% | +59.92% | +81.78% | 2.75TCr | |
| Weighted average by Cap. | -1.03% | +0.11% | +94.86% | +122.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.66 0.57 0.53 0.49 0.91 62.17 0.91 6.29 2.44 31.86 2.47 2.42 102.79 | 1.31 1.13 1.06 0.97 1.81 123.88 1.82 12.54 4.86 63.48 4.92 4.82 204.81 |
| Net income | 47.96L 41.3L 38.8L 35.47L 66.36L 45Cr 66.59L 4.59Cr 1.78Cr 23Cr 1.8Cr 1.76Cr 75Cr | -83.07L -71.54L -67.2L -61.44L -1.15Cr -78Cr -1.15Cr -7.95Cr -3.08Cr -40Cr -3.12Cr -3.05Cr -129.77Cr |
| Net Debt | 1L 1L 98.7T 90.23T 2L 1.15Cr 2L 11.67L 5L 59.08L 5L 4L 1.91Cr | 6L 5L 5L 4L 8L 5.73Cr 8L 57.96L 22.47L 2.93Cr 22.75L 22.26L 9.47Cr |
Employees
45
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $1.860 | -4.62% | 84,670 |
| 03/26/03 | $1.950 | -16.67% | 1,91,665 |
| 02/26/02 | $2.340 | -4.88% | 16,11,978 |
| 01/26/01 | $2.460 | -1.60% | 56,454 |
| 31/26/31 | $2.500 | -0.40% | 24,866 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCNI Stock
Select your edition
All financial news and data tailored to specific country editions
